Document is current
Any future updates will be listed below
-
Authors
Morimoto, Kenji
Yamada, Tadaaki
Sawada, Ryo
Azuma, Koichi
Goto, Yasuhiro
Harada, Taishi
Shiotsu, Shinsuke
Tamiya, Nobuyo
Chihara, Yusuke
Takeda, Takayuki
Hiranuma, Osamu
Hasegawa, Isao
Tanaka, Satomi
Yoshimura, Akihiro
Iwasaku, Masahiro
Tokuda, Shinsaku
Kim, Young Hak
Takayama, Koichi
- License Information
-
More Information
Article History
Received: 11 August 2022
Accepted: 5 January 2023
First Online: 9 January 2023
Declarations
:
: TY received grants from Pfizer, Ono Pharmaceutical, Janssen Pharmaceutical, and Takeda Pharmaceutical and personal fees from Eli Lilly. KA received personal fees from Ono Pharmaceutical, Chugai Pharmaceutical, AstraZeneca, MSD Oncology, and Bristol-Myers Squibb outside the submitted work. KT received grants from Chugai Pharmaceutical and Ono Pharmaceutical and personal fees from AstraZeneca, Chugai Pharmaceutical, MSD, Eli Lilly, Boehringer Ingelheim, and Daiichi Sankyo. The other authors have no further conflicts of interest to declare.
: The study protocol was approved by the ethics committee of each hospital, including the Kyoto Prefectural University of Medicine (Approval no. ERB-C-1918).
: Because this was a retrospective study, the need for informed consent was waived, and an official website was used as an opt-out method.
: Not required.
